The Latest Cardiac and Vascular News
WAYNE, Pa.–(BUSINESS WIRE)–XyloCor Therapeutics, a clinical-stage biopharmaceutical company developing novel gene therapies for cardiovascular disease, today reported positive 12-month data from the Phase 2 portion of its Phase 1/2 clinical trial (EXACT) designed to assess the safety and provide preliminary evidence of efficacy of lead gene therapy candidate XC001 (encoberminogene […]
PITTSBURGH–(BUSINESS WIRE)–PECA Labs, a medical device company reimagining the field of vascular grafts and valves with durable polymeric cardiovascular devices designed to fit, grow, and last, has announced it has added Dr. Jeffrey P. Carpenter, Jeffrey O’Donnell, Sr. and Samuel E. Navarro to its board of directors. The new board […]
SANTA CLARA, Calif., July 18, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular disease, will report financial results for the second quarter 2023 after market close on Monday, August 7, 2023. Company management will host […]
TOKYO, EMERYVILLE, Calif. and COLUMBIA, Md., July 18, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Eko Health Inc. (Co-Founder and CEO: Connor Landgraf, “Eko”) announced today that they have entered into a License & Supply Agreement for the global supply and license of Eko’s latest digital stethoscope, the CORE 500™, and […]
SOUTHLAKE, Texas, July 18, 2023 /PRNewswire/ — Renibus Therapeutics, Inc., (“Renibus”), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio-renal diseases, today announced raising $47 million from the initial closings of a Series B financing. Proceeds from the financing will be used to advance RBT-1 through a pivotal Phase 3 trial for its […]
COPENHAGEN, Denmark, July 18, 2023 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to support clinical decision making in the EP lab, today announced its most recent financing round of $9 million from investors. CathVision secures $9 Million in funding to advance commercial operations driving adoption of the ECGenius™ System The […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix Inc. a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced today that the first patients underwent Percutaneous Transmural Arterial Bypass (PTAB) using the DETOUR system, since FDA approval of the system was granted. This marks the official […]
EATONTOWN, N.J., July 17, 2023 (GLOBE NEWSWIRE) — Avertix Medical, Inc. (“Avertix” or the “Company”), formerly known as Angel Medical Systems, Inc., a healthcare technology company commercializing the first and only FDA-approved heart attack warning system to improve long-term management and outcomes of high-risk coronary disease in patients, announced today that Professor Ian […]
PHILADELPHIA, July 17, 2023 (GLOBE NEWSWIRE) — ŌNŌCOR LLC, a medical technology company dedicated to developing essential safety tools and other facilitating technologies for the modern-day catheterization lab, today announced that they have signed an exclusive distribution agreement with B. Braun Interventional Systems Inc. (BIS) as an important next step in preparation for […]
PALO ALTO, Calif., July 17, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), is a commercial-stage biopharmaceutical company focused on genetic diseases and cancers. Today, alongside the dedicated physicians and courageous patients who participated, the Company reports positive results from ATTRibute-CM, its Phase 3 study […]
